A detailed history of Verition Fund Management LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 11,000 shares of CLPT stock, worth $202,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$202,620
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $58,300 - $144,980
11,000 New
11,000 $123,000
Q2 2023

Aug 14, 2023

BUY
$6.54 - $10.58 $73,915 - $119,575
11,302 New
11,302 $81,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $451M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.